Intracellular Th's activity chart (see below) currently has 318 price targets and 219 ratings on display.
Analysts' price targets on this stock were met 90.06% of the time, taking 370.08 days on average.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 02-Apr-2025. First documented stock forecast 14-Apr-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Apr-2025
$132
$132
1 years 7 months 18 days ago
(02-Apr-2025)
26/28 (92.86%)
$0.13 (0.10%)
512
Hold Since 28-Feb-2025
$132
$132
1 years 8 months 23 days ago
(28-Feb-2025)
12/14 (85.71%)
$3.8 (2.96%)
738
Buy Since 10-Dec-2020
$132
$140
1 years 8 months 27 days ago
(24-Feb-2025)
14/16 (87.5%)
$3.43 (2.67%)
274
Hold Since 21-Feb-2025
$100
1 years 8 months 30 days ago
(21-Feb-2025)
24/25 (96%)
$-27.19 (-21.38%)
152
Hold Since 08-Aug-2024
$132
$87
1 years 9 months 15 days ago
(05-Feb-2025)
7/8 (87.5%)
$4.97 (3.91%)
209
What is ITCI (Intracellular Th) average time for price targets to be met?
Which analyst most recently updated their price target on ITCI (Intracellular Th)?
Which analyst has the most public recommendations on ITCI (Intracellular Th)?
Which analyst is the currently most bullish on ITCI (Intracellular Th)?
Which analyst is the currently most reserved on ITCI (Intracellular Th)?